Submission Guidelines
General Guidelines
Abstract submissions can only be made electronically through the congress website.
An abstract can be submitted to the COA2017 if it has not been published previously.
Please submit the abstract by following the submission procedures.
Please note that abstracts submitted by e-mail, mail or fax CANNOT be accepted.
Each individual may submit more than one abstract with the same account.
The first author must present his/her presentation.
Abstracts received after the deadline will not be accepted and will therefore not be considered for the program or for publication.
Abstract Preparation
Abstract Title
There is a limit of 100 words, including spaces, for the title of an abstract.
Identifying information such as author or institution names should not be included in the title.
Only enter the title in the title field and do not include it in the body of the abstract.
Abstract Body
Abstract titles, author names, author institutions, and information in tables and images do not count toward the 1,000 words limit.
Abstract must be submitted in English and should be written with clear paragraphs for “Objectives,” “Materials and Methods,” “Result” and “Conclusion.
Tables and Images
Do not include any figures, tables, charts, references or illustrations in the abstract’s body.
Abbreviations
Abbreviations should conform to the recommendations made by the IUB Committee of Editors on Biochemical Journals.
Use the abbreviation in parentheses after the full word the first time it appears. Use no more than three nonstandard abbreviations.
Presentation Preferences
Oral
Poster
E-Poster
Published only
Submission Procedure
Before submitting your abstract, you have to create your personal account. During the submission period, you may edit your abstract with this ID and the password. Please retain them safely for future reference.
To log in to your account, you will need your registered username and password.
To start a new submission, you are required to select the submission type first (whether you are the first author), and choose one presentation preference before abstract categories.
You may add additional authors and Institutions and make sure they are in the correct order.
Review & Submit allows you to preview the information that was entered on each step of the submission process and a green check mark will display at the center of the step if it was completed successfully.
Once submission is completed, you will automatically receive an e-mail confirming the receipt of your abstract submission. If you do not receive this e-mail within 30 minutes after submission, there is a possibility that your submission has not been processed successfully. You may check your submission status through “ Abstract Management ” section.
After the deadline for abstract submission, any change related to abstracts cannot be made. Please make sure all the submitted information is accurate before the deadline.
Publication Policy
All accepted abstracts will be included in the Proceedings of the Congress. The format will be electronic only and it will be part of the Congress kit.
Speaker Disclosure of Potential Conflicts of Interest
The Scientific Committee requires that all presentations be as free of commercial bias as possible and that any information on commercial products or services be based on already generally accepted medical thinking. It is also preferred that generic drug names be used wherever possible and that any presentation referring to unlabelled or research-associated commercial products should disclose this situation to session attendees.
Review Process
The reviewers will judge the abstracts according to the relevance to COA2017, standard of English, objectivity of statements, description of what was done, suitability of methods to aims, conclusions confirmed by objective results, ethics, scientific value, potential clinical value, originality of work and overall impression.
Notification of Acceptance
Acceptance or rejection of an abstract is based on the average grade awarded by the reviewers.
The submitting authors will be notified by Late Sepetember at the e-mail address (submitting author) provided during registration, whether their abstract has been accepted.
It is the author’s responsibility to ensure that e-mails from COA2017 can reach them.
Abstract Withdrawal Policy
If for some reason the submitting author wishes to withdraw their abstract submission, please send an Email to the Congress secretariat including their abstract number and reason for withdraw. The abstract will be deleted from the submission system once the withdraw application is acknowledged.
-
NOTIFICATION OF ABSENCE
November 1, 2017
-
E-POSTER SUBMISSION DEADLINE
November 10, 2017
-
ADVANCED REGISTRATION DEADLINE
October 23, 2017
-
ON-SITE REGISTRATION DATE
November 14, 2017
- Secretariat
- No. 42,West Street Dongsi Beijing China 100710
- http://2017.coachina.org
- Abstract Submission, Online Registration
- 010-8929 2552-807/819/823 /+86 13716464084
- registration@coachina.org
- Exhibition, Industry Relations
- 18701292810
- industry@coachina.org